Autres langues Revenio Group Oyj

Actions

REG1V

FI0009010912

Equipement et technologie médicale avancés

Temps réel estimé Tradegate Autres places de cotation 16:37:02 12/05/2026			Varia. 5j.	Varia. 1 janv.
13,48 ^EUR	-1,61%		0,00%	-39,73%

29/04	DNB Carnegie abaisse sa recommandation sur Revenio Group à 'conserver' contre 'acheter', objectif de cours ramené à 15 euros (20,80)	FW
28/04	Transcript : Revenio Group Oyj, Q1 2026 Earnings Call, Apr 28, 2026

Autres langues

28/04	Revenio Group Corporation: Interim Report January 1 – March 31, 2026
28/04	Revenio Group Oyj Reports Earnings Results for the First Quarter Ended March 31, 2026
23/04	Revenio Group – Consensus estimates Q1 2026
17/04	Revenio’s Interim report January-March 2026 to be published on April 28, 2026
15/04	Revenio Group Oyj Proposes No Dividend for the Financial Year 2025
15/04	Notice to the Annual General Meeting of Revenio Group Corporation
13/04	Revenio Group Oyj signed an agreement to acquire Visionix International SAS for approximately ?240 million.
13/04	Revenio Oyj : to arrange a press conference on the Visionix acquisition today April 13, 2026 at 2.00 p.m.
13/04	Revenio Group cancels AGM 2026 scheduled for April 15
13/04	Revenio acquires visual healthcare solutions company Visionix
13/04	Revenio Group Corporation cancels its Annual General Meeting 2026 and moves it to a later date
13/04	Inside information: Revenio accelerates growth and value creation by acquiring Visionix, becoming a leading turnkey solutions provider in the global eye care market
23/03	Revenio Group Corporation: Notice to the Annual General Meeting 2026
23/03	Revenio Oyj : Report by the Board of Directors and Financial Statements 2025
23/03	Revenio Oyj : Remuneration report 2025
23/03	Revenio Oyj : Corporate governance statement 2025
23/03	Revenio Oyj : Group Corporation's Annual reporting package 2025 has been published
23/03	Revenio Group Corporation’s Annual reporting package 2025 has been published
17/03	Change in the amount of Revenio Group Corporation’s treasury shares
12/03	Revenio Group appoints Juha Jaatinen as interim CFO
12/03	Revenio Group Corporation appoints Juha Jaatinen as Interim Chief Financial Officer
18/02	The realization of Revenio Group Corporation’s share plan RSP 2024-2026 for the year 2025
12/02	Revenio subsidiary iCare partners with Mediwhale
12/02	ICare partners with Mediwhale on AI-powered cardiovascular disease prevention
11/02	Revenio Group Oyj Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025